Status:
COMPLETED
NovellusDx Tissue Collection Protocol
Lead Sponsor:
Fore Biotherapeutics
Conditions:
Patients That Have Been Diagnosed With Colorectal Cancer
Patients Eligible for Tumor Biopsy
Eligibility:
All Genders
18-85 years
Brief Summary
NovellusDx is developing a diagnostic platform for the personalized cancer therapy based on patient derived tumor tissue. The assay is able to sense activating mutations by monitoring their effect on ...
Eligibility Criteria
Inclusion
- Patients that have been diagnosed positive for colon cancer.
- available treatment follow up during cancer treatment
Exclusion
- None
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01791322
Start Date
January 1 2014
End Date
June 1 2016
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pathology Lab Hadassah Medical Center
Jerusalem, Israel, 91120